Obesity may attenuate the HbA1c‐lowering effect of sitagliptin in Japanese type 2 diabetic patients

por Bando, Yukihiro, Kanehara, Hideo, Aoki, Keiko, Hisada, Azusa, Toya, Daisyu, Tanaka, Nobuyoshi
Publicado 2011

Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus

por Bando, Yukihiro, Tohyama, Hitomi, Aoki, Keiko, Kanehara, Hideo, Hisada, Azusa, Okafuji, Kazuhiro, Toya, Daisyu
Publicado 2016

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy

por Takazakura, Akiko, Sakurai, Masaru, Bando, Yukihiro, Misu, Hirofumi, Takeshita, Yumie, Kita, Yuki, Shimizu, Akiko, Hayakawa, Tetsuo, Kato, Ken-ichiro, Kaneko, Shuichi, Takamura, Toshinari
Publicado 2015

Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association

por Shimada, Akihiro, Kimura, Hideki, Oida, Koji, Kanehara, Hideo, Bando, Yukihiro, Sakamoto, Shinobu, Wakasugi, Takanobu, Saga, Takashi, Ito, Yasuki, Kamiyama, Kazuko, Mikami, Daisuke, Iwano, Masayuki, Hirano, Tsutomu, Yoshida, Haruyoshi
Publicado 2016